January 31, 2025
In its first meeting of 2025, the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) gave the green light for the first […]
January 31, 2025
The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine [21-valent]) intended to prevent invasive disease and pneumonia […]
January 31, 2025
Europe’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for ivermectin–albendazole to treat soil-transmitted helminth infections, including the neglected tropical disease lymphatic […]
January 29, 2025
The US Food and Drug Administration (FDA) approved semaglutide (Ozempic, Novo Nordisk) for reducing the risk for worsening kidney disease and cardiovascular death in adults with […]
January 24, 2025
The US Food and Drug Administration (FDA) has approved a supplemental new drug application allowing esketamine nasal spray (Spravato; Johnson & Johnson) to be used as […]
January 23, 2025
The US Food and Drug Administration (FDA) has approved treosulfan (Grafapex, Medexus Pharmaceuticals) in combination with fludarabine as a preparative regimen to clear bone marrow before […]
January 22, 2025
The US Food and Drug Administration (FDA) has added a boxed warning to the label of multiple sclerosis drug glatiramer acetate about the risk of anaphylaxis. From […]
January 17, 2025
The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal […]
January 10, 2025
“Out of an abundance of caution,” Johnson & Johnson MedTech has temporarily paused the use of its Varipulse field ablation system in the United States, the […]